Strain-Dependent Variability of Early Discovery Small Molecule Pharmacokinetics in Mice: Does Strain Matter?

Drug discovery programs routinely perform pharmacokinetic (PK) studies in mice to prioritize lead compounds based on anticipated exposure-efficacy and exposure-toxicity relationships. Because of logistical and/or technical issues, the strain of mouse in early discovery PK studies may not always match the strain in toxicity or efficacy studies. This elicits the question do appreciable strain-dependent differences in PK parameters exist to an extent that would warrant conducting PK studies in a strain that matches efficacy and toxicity models? To understand the impact that strain may have on PK parameters, we selected eight marketed drugs with well characterized absorption, distribution, metabolism, and excretion properties and diverse structures to perform PK studies in three common mouse strains (Bagg Albino c, C57BL/6, and CD-1). Some statistical strain-dependent differences were observed; however, we found good general agreement of PK parameters between strains: 88%, 100%, 75%, 76%, 94%, and 88% of compounds were within twofold across strains for clearance, volume of distribution at steady state, t1/2, Cmax, Tmax, and oral bioavailability, respectively. Overall, we recommend that an approach using a single strain of mouse is appropriate for discovery screening PK studies, provided that proper caution is exercised. SIGNIFICANCE STATEMENT The mouse strain in discovery pharmacokinetic (PK) studies may not match the strain in efficacy and toxicology studies. Currently, there is a gap in the literature addressing whether differences in PK parameters across mouse strains exist such that multiple PK studies are warranted. The results from this study indicated that the PK properties of clinically used drugs between mouse strains are within an acceptable range such that single strain PK is appropriate.

[1]  Julie M. Lade,et al.  Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species Surrogate , 2019, Drug Metabolism And Disposition.

[2]  A. Zhang,et al.  Strain differences between CD-1 and C57BL/6 mice in expression of metabolic enzymes and DNA methylation modifications of the primary hepatocytes. , 2019, Toxicology.

[3]  Kung-I Feng,et al.  Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species. , 2017, Molecular pharmaceutics.

[4]  E. Schuetz,et al.  Interindividual Variability in Cytochrome P450–Mediated Drug Metabolism , 2016, Drug Metabolism and Disposition.

[5]  Khaled Abduljalil,et al.  Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations , 2014, Drug Metabolism and Disposition.

[6]  Leming Shi,et al.  Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters , 2013, PloS one.

[7]  J. Isbell,et al.  Interstrain differences of in vitro metabolic stability and impact on early drug discovery. , 2010, Journal of pharmaceutical sciences.

[8]  R. Tyndale,et al.  Characterization and Comparison of Nicotine and Cotinine Metabolism in Vitro and in Vivo in DBA/2 and C57BL/6 Mice , 2007, Molecular Pharmacology.

[9]  Zhaomei Zhang,et al.  In silico pharmacogenetics of warfarin metabolism , 2006, Nature Biotechnology.

[10]  K. Gingrich,et al.  The distribution of cocaine in mice differs by age and strain. , 2004, Neurotoxicology and teratology.

[11]  S. Ekman,et al.  Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  D. MacCallum,et al.  Influence of grapefruit juice on itraconazole plasma levels in mice and guinea pigs. , 2002, The Journal of antimicrobial chemotherapy.

[13]  D. G. Walters,et al.  Sex and strain differences in mouse hepatic microsomal coumarin 7-hydroxylase activity. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.